Plus Therapeutics Inc (PSTV)
1.20
+0.01
(+0.84%)
USD |
NASDAQ |
Nov 21, 16:00
1.19
-0.01
(-0.83%)
After-Hours: 20:00
Plus Therapeutics Enterprise Value: 5.580M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 5.580M |
| November 20, 2024 | 5.521M |
| November 19, 2024 | 5.815M |
| November 18, 2024 | 5.521M |
| November 15, 2024 | 5.403M |
| November 14, 2024 | 5.933M |
| November 13, 2024 | 6.228M |
| November 12, 2024 | 6.110M |
| November 11, 2024 | 5.521M |
| November 08, 2024 | 5.756M |
| November 07, 2024 | 6.523M |
| November 06, 2024 | 6.936M |
| November 05, 2024 | 6.523M |
| November 04, 2024 | 6.524M |
| November 01, 2024 | 6.464M |
| October 31, 2024 | 6.258M |
| October 30, 2024 | 6.287M |
| October 29, 2024 | 6.464M |
| October 28, 2024 | 6.439M |
| October 25, 2024 | 6.464M |
| October 24, 2024 | 6.465M |
| October 23, 2024 | 6.641M |
| October 22, 2024 | 6.657M |
| October 21, 2024 | 6.759M |
| October 18, 2024 | 6.995M |
| Date | Value |
|---|---|
| October 17, 2024 | 6.818M |
| October 16, 2024 | 6.936M |
| October 15, 2024 | 6.818M |
| October 14, 2024 | 6.287M |
| October 11, 2024 | 6.582M |
| October 10, 2024 | 6.169M |
| October 09, 2024 | 6.523M |
| October 08, 2024 | 6.464M |
| October 07, 2024 | 6.818M |
| October 04, 2024 | 6.169M |
| October 03, 2024 | 6.188M |
| October 02, 2024 | 6.818M |
| October 01, 2024 | 6.228M |
| September 30, 2024 | 7.113M |
| September 27, 2024 | 5.765M |
| September 26, 2024 | 3.937M |
| September 25, 2024 | 3.937M |
| September 24, 2024 | 3.878M |
| September 23, 2024 | 4.232M |
| September 20, 2024 | 4.527M |
| September 19, 2024 | 4.291M |
| September 18, 2024 | 4.409M |
| September 17, 2024 | 4.232M |
| September 16, 2024 | 3.760M |
| September 13, 2024 | 3.584M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-4.711M
Minimum
May 11 2022
26.22M
Maximum
Feb 24 2021
5.961M
Average
4.099M
Median
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | -63.40M |
| Retractable Technologies Inc | -17.27M |
| InfuSystems Holdings Inc | 224.07M |
| Xtant Medical Holdings Inc | 85.83M |
| Catheter Precision Inc | 3.891M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.874M |
| Total Expenses (Quarterly) | 3.799M |
| EPS Diluted (Quarterly) | -0.37 |
| Earnings Yield | -210.8% |
| Normalized Earnings Yield | -260.57 |